ViroGates A/S develops and markets prognostic products for the healthcare sector. Its products include suPARnostic TurbiLatex, suPARnostic Quick Triage, and suPARnostic ELISA. The products of the company are used for the prognosis of lifestyle-related diseases, such as cardiovascular disease, type 2 diabetes, cancer, and emergency services to make a clinical decision on hospitalization or discharge of acute medical patients. The company was founded by Jesper Eugen-Olsen, Jørgen Axel Thorball, and Peter James Arthur Benson in 2001 and is headquartered in Birkerod, Denmark.